USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'Inhalation Product Testing'
- Did you mean
- insulation product testing
- inflation product testing
- Related search terms
- Product and Pipeline Analysis of the Global Therapeutic Lipid Modulators Market
- Products from Food Waste Market
- products frost food waste market
- products fa02 food waste market
- products fall food waste market
-
30 Mar 2016 | Global | Technology Research
Next Generation Diabetes Therapy and Drug Delivery Technologies
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Mar 2015 | Global | Market Research
Analysis of the Global Diabetes Drug Delivery Market
Future Options for End Users
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Jul 2015 | North America | Market Research
Analysis of the US and European Diabetes Diagnostics Market
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
$6,950.00
Special Price $5,212.50 save 25 %
-
This research service covers the pharmaceutical industry development pipeline for diabetes mellitus in the United States, with 2005 as the base year. Included are both the products projected to enter the market by the end of the forecast coverage period in 2012, as well as products entering the market in 2005 that correspond to the in-depth discuss...
$4,950.00
Special Price $3,712.50 save 25 %
